Pre-diabetes is an artificial category with virtually zero clinical relevance, says lead author John S Yudkin, Emeritus Professor of Medicine at UCL. There is no proven benefit of giving diabetes treatment drugs to people in this category before they develop diabetes, particularly since many of them would not go on to develop diabetes anyway.